369 related articles for article (PubMed ID: 19016068)
1. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
2. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
[TBL] [Abstract][Full Text] [Related]
6. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
Kim JE; Park YJ
Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo.
Huang Y; Chen XM; Zhao BX; Ke XY; Zhao BJ; Zhao X; Wang Y; Zhang X; Zhang Q
AAPS PharmSciTech; 2010 Jun; 11(2):752-9. PubMed ID: 20443090
[TBL] [Abstract][Full Text] [Related]
10. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
[TBL] [Abstract][Full Text] [Related]
13. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
[TBL] [Abstract][Full Text] [Related]
14. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
[TBL] [Abstract][Full Text] [Related]
15. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
[TBL] [Abstract][Full Text] [Related]
16. Liposomes actively recognizing the glucose transporter GLUT
Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
[TBL] [Abstract][Full Text] [Related]
17. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
18. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
[TBL] [Abstract][Full Text] [Related]
19. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
20. Multimeric System of RGD-Grafted PMMA-Nanoparticles as a Targeted Drug- Delivery System for Paclitaxel.
Gibbens-Bandala BV; Ocampo-García BE; Ferro-Flores G; Morales-Avila E; Ancira-Cortez A; Jaimes-Aguirre L
Curr Pharm Des; 2017; 23(23):3415-3422. PubMed ID: 28403791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
